WeVote
Log In

Bill

Bill

HD 2283

An Act relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth

194th Legislature (2025-2026) Introduced by Alyson Sullivan-Almeida

Massachusetts bill establishes minimum pharmacy reimbursement rates from pharmacy benefit managers to prevent below-cost payments threatening independent pharmacy viability.

0
WeVote Research Nonpartisan
Bill Summary · HD 2283

Legislative bill overview

HD 2283 would regulate how pharmacy benefit managers (PBMs) reimburse pharmacies for prescription medications in Massachusetts. The bill aims to establish fair reimbursement rates by preventing PBMs from paying pharmacies less than their actual acquisition costs plus reasonable dispensing fees. This addresses concerns that PBMs have been squeezing pharmacy profit margins through below-cost reimbursements.

Why is this important

Pharmacy closures and consolidation have accelerated partly due to unsustainable reimbursement rates, affecting medication access in underserved areas. Independent pharmacies argue they cannot survive on current PBM payments, while chain pharmacies can absorb losses through volume. Fair reimbursement rates could preserve competitive pharmacy markets and maintain local healthcare access points.

Potential points of contention

  • Cost-shifting concerns: PBMs and insurers may argue that stricter reimbursement floors will increase medication costs for consumers and employers who ultimately pay for insurance premiums
  • Definition disputes: Defining "actual acquisition costs" and "reasonable dispensing fees" precisely enough to prevent litigation while avoiding loopholes remains technically challenging
  • Market complexity: PBMs argue they negotiate rebates and manage costs holistically; mandating floor reimbursement rates may disrupt those business models and reduce negotiating leverage against drug manufacturers

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.